WithdrawnPhase 3

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Stopped: Undefined

Mexico0Started 2006-03

Plain-language summary

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Advanced diabetic retinopathy with retinal detachment Exclusion Criteria: * Retinal detachments of more than 6 months

What they're measuring

Surgical time

Facility of surgical maneuvers

Trial details

NCT IDNCT00407108

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-03

View on ClinicalTrials.gov More Diabetic Retinopathy trials